Baylor Genetics / coverage

Additional coverage:

About

Baylor Genetics developed AI-MARRVEL, a machine learning tool to help diagnose rare genetic disorders, and published the results in a peer-reviewed study in NEJM. The challenge was turning a technical publication into coverage that clinicians and genomics leaders would see.

SVM secured and coordinated an interview with GenomeWeb on the study, resulting in an article on how Baylor’s tool shows promise for clinical rare variant interpretation.

The story then spread to HealthDay, Physicians Weekly, News-Medical, SciTechDaily, AZO Robotics, Front Line Genomics, and Bio-IT World/Diagnostics World, reaching physicians, researchers, and AI audiences alike.

Additional coverage included: